{"id":699211,"date":"2026-05-29T17:59:08","date_gmt":"2026-05-29T21:59:08","guid":{"rendered":"https:\/\/goldtadise.com\/?p=699211"},"modified":"2026-05-29T17:59:08","modified_gmt":"2026-05-29T21:59:08","slug":"largest-human-cancer-study-of-ivermectin-mebendazole-is-now-peer-reviewed-and-published-in-a-major-cancer-journal","status":"publish","type":"post","link":"https:\/\/goldtadise.com\/?p=699211","title":{"rendered":"Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal"},"content":{"rendered":"<h4>84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.<\/h4>\n<p>Our study, \u201cReal-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,\u201d is now peer-reviewed and published in Anticancer Research\u2014a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.<\/p>\n<p><a href=\"https:\/\/x.com\/NicHulscher\/status\/2060366485730525399\">https:\/\/x.com\/NicHulscher\/status\/2060366485730525399<\/a><\/p>\n<h3>AND<\/h3>\n<h4>Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort<\/h4>\n<p><a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\">https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, \u201cReal-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,\u201d is now &hellip; <a href=\"https:\/\/goldtadise.com\/?p=699211\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2948,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-699211","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/699211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/users\/2948"}],"replies":[{"embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=699211"}],"version-history":[{"count":1,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/699211\/revisions"}],"predecessor-version":[{"id":699212,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/699211\/revisions\/699212"}],"wp:attachment":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=699211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=699211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=699211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}